Adjusting the TMIST study design to accommodate slower than expected accrual: ECOG-ACRIN EA1151. A phase 3 study to determine the breast cancer risk reducing effect of denosumab in women carrying a ...
Vasectomy is more cost-effective at a $100,000 willingness-to-pay (WTP) threshold. Salpingectomy may prevent more pregnancies and reduces ovarian cancer risk. Salpingectomy becomes the more ...